The challenge of developing a physiologically relevant dissolution test to satisfy regulatory
agencies has pushed drug manufacturers to engage in “design of experiment” method development,
which helps manufacturers address variability, dissolution medium, and surfactant use-all of which will
Keywords: Dissolution, design of experiments, variability, FDA guidances, method development, f2.
Rights & PermissionsPrintExport